Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Clinical trial NCT02836496 · COMPLETED
Trial details
- NCT number
- NCT02836496
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2019-08-08
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.